Dr. Rabin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
# Dana
Boston, MA 02115Phone+1 617-632-6049Fax+1 617-632-5786
Education & Training
Beth Israel Hospital1985 - 1988
NYU Grossman School of MedicineResidency, Internal Medicine, 1981 - 1984
Weill Cornell MedicineClass of 1981
Certifications & Licensure
NY State Medical License 1982 - Present
NH State Medical License 2009 - 2026
MA State Medical License 1987 - 2025
CT State Medical License 2014 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 692 citationsGenomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic TargetsPriscilla K. Brastianos, Scott L. Carter, Sandro Santagata, Daniel P. Cahill, Amaro Taylor-Weiner
Cancer Discovery. 2015-11-01 - 469 citationsExon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or ...David M. Jackman, Beow Y. Yeap, Lecia V. Sequist, Neal I. Lindeman, Alison J. Holmes
Clinical Cancer Research. 2006-07-01 - 500 citationsAssessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib.Geoffrey R. Oxnard, Yuebi Hu, Kathryn Finch Mileham, Hatim Husain, Daniel B. Costa
JAMA Oncology. 2018-11-01
Press Mentions
Effect of Erlotinib plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical TrialAugust 8th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
